1. Derazantinib: an investigational drug for the treatment of cholangiocarcinoma. (2nd November 2021) Authors: Braun, Stephan; McSheehy, Paul; Litherland, Karine; McKernan, Phil; Forster-Gross, Nicole; Bachmann, Felix; El-Shemerly, Mahmoud; Dimova-Dobreva, Miryana; Polyakova, Inessa; Häckl, Manuel; Zhou, Ping; Lane, Heidi; Kellenberger, Laurenz; Engelhardt, Marc Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 11(2021) Page Start: 1071 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗